Perinatal outcomes and survival predictors of severe red‐cell alloimmunization treated by intrauterine transfusion

2021 ◽  
Author(s):  
Erol Arslan ◽  
Suleyman Cansun Demir ◽  
Mehmet Ozsurmeli ◽  
Cigdem Akcabay
Keyword(s):  
Perinatal Outcomes ◽  
Red Cell ◽  
Intrauterine Transfusion ◽  
Survival Predictors

scholarly journals Sonographic Demonstration of Intracranial Hemorrhage in a Fetus with Hydrops Fetalis due to Rh Alloimmunization after Intrauterine Intravascular Transfusion: A Case Report and Review of the Literature

2018 ◽  
Vol 2018 ◽  
pp. 1-5
Author(s):  
Rauf Melekoglu ◽  
Ebru Celik ◽  
Hasim Kural
Keyword(s):  
Case Report ◽  
Intracranial Hemorrhage ◽  
Intraventricular Hemorrhage ◽  
Case Reports ◽  
Rare Complication ◽  
Fetal Anemia ◽  
Red Cell ◽  
Review Of The Literature ◽  
Intrauterine Transfusion ◽  
Sonographic Demonstration

Intrauterine transfusion is the most common and successful intrauterine procedure for the treatment of fetal anemia due to red cell alloimmunization. Fetal intracranial hemorrhage is a very rare complication of intrauterine transfusion in patients with Rh(D) alloimmunization and it has been demonstrated only in a few case reports in the literature. Herein, we described a case of grade IV intraventricular hemorrhage that was diagnosed following the first intrauterine transfusion and reviewed the literature about the fetal intracranial hemorrhage that occurred after intrauterine intravascular transfusion procedure.

412: Increased risk of intravascular intrauterine transfusion before 20 weeks gestation in the treatment of severe red cell alloimmunization

2011 ◽  
Vol 204 (1) ◽  
pp. S166-S167
Author(s):  
Irene T.M. Lindenburg ◽  
Inge L. van Kamp ◽  
Johanna M. Middeldorp ◽  
Frans J.C.M. Klumper ◽  
Dick Oepkes
Keyword(s):  
Red Cell ◽  
Increased Risk ◽  
Intrauterine Transfusion

The Effect of Intrauterine Transfusion on Fetal Bilirubin in Red Cell Alloimmunization

1997 ◽  
Vol 89 (1) ◽  
pp. 57-60 ◽  
Author(s):  
L Goodrum
Keyword(s):  
Red Cell ◽  
Intrauterine Transfusion

Perinatal outcomes of intrauterine transfusion for foetal anaemia due to red blood cell alloimmunisation

2019 ◽  
Vol 40 (5) ◽  
pp. 649-653
Author(s):  
Ayşe Özge Şavkli ◽  
Berna Aslan Çetin ◽  
Zuat Acar ◽  
Zeynep Özköse ◽  
Mustafa Behram ◽  
...  
Keyword(s):  
Blood Cell ◽  
Red Blood Cell ◽  
Perinatal Outcomes ◽  
Intrauterine Transfusion

Perinatal outcomes of intrauterine transfusion for the surviving twin in monochorionic twin gestation involving a single fetal demise

2020 ◽  
Vol 46 (8) ◽  
pp. 1319-1325
Author(s):  
Masako Kanda ◽  
Shohei Noguchi ◽  
Ryo Yamamoto ◽  
Haruna Kawaguchi ◽  
Shusaku Hayashi ◽  
...  
Keyword(s):  
Perinatal Outcomes ◽  
Fetal Demise ◽  
Monochorionic Twin ◽  
Intrauterine Transfusion

scholarly journals Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn

Hematology ◽  
2015 ◽  
Vol 2015 (1) ◽  
pp. 146-151 ◽  
Author(s):  
Meghan Delaney ◽  
Dana C. Matthews
Keyword(s):  
Heart Failure ◽  
Pregnant Women ◽  
Blood Group ◽  
Acute Phase ◽  
Maternal Blood ◽  
Fetal Anemia ◽  
Red Cell ◽  
Hemolytic Disease ◽  
Cell Destruction ◽  
Intrauterine Transfusion

AbstractHemolytic disease of the fetus and newborn (HDFN) affects 3/100 000 to 80/100 000 patients per year. It is due to maternal blood group antibodies that cause fetal red cell destruction and in some cases, marrow suppression. This process leads to fetal anemia, and in severe cases can progress to edema, ascites, heart failure, and death. Infants affected with HDFN can have hyperbilirubinemia in the acute phase and hyporegenerative anemia for weeks to months after birth. The diagnosis and management of pregnant women with HDFN is based on laboratory and radiographic monitoring. Fetuses with marked anemia may require intervention with intrauterine transfusion. HDFN due to RhD can be prevented by RhIg administration. Prevention for other causal blood group specificities is less studied.

Red cell alloimmunisation following intrauterine transfusion and the feasibility of providing extended phenotype-matched red cell units

2014 ◽  
Vol 24 (5) ◽  
pp. 311-315 ◽  
Author(s):  
B. Doyle ◽  
J. Quigley ◽  
M. Lambert ◽  
J. Crumlish ◽  
C. Walsh ◽  
...  
Keyword(s):  
Red Cell ◽  
Extended Phenotype ◽  
Intrauterine Transfusion

scholarly journals Enhancement of Antibody Titre and Development of Additional Red Cell Alloantibodies Following Intrauterine Transfusion

2013 ◽  
Vol 32 (1) ◽  
pp. 92-94 ◽  
Author(s):  
Anju Dubey ◽  
Atul Sonker ◽  
Rajendra Chaudhary
Keyword(s):  
Antibody Titre ◽  
Red Cell ◽  
Intrauterine Transfusion

Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis

2019 ◽  
Vol 46 (6) ◽  
pp. 425-432
Author(s):  
John W. Snelgrove ◽  
Rohan D’Souza ◽  
P. Gareth R. Seaward ◽  
Rory Windrim ◽  
Edmond N. Kelly ◽  
...  
Keyword(s):  
Survival Analysis ◽  
Perinatal Outcomes ◽  
Time To Event ◽  
Intrauterine Transfusion
Sign in / Sign up

Export Citation Format

Share Document